Schrodinger Profit Margin

The latest profit margin for SDGR is -40.6% as of March 2026. That compares with -83.39% in the prior-year period — up 51.3% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Schrodinger's historical trend and sector peers before judging valuation or financial health.

Over the past year, SDGR's profit margin moved from -83.39% to -40.6% — a 51.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Schrodinger's valuation or profitability profile.

Against Healthcare companies, SDGR currently prints -40.6% for profit margin, while the sector average sits near 15.58%. That is roughly 360.5% below the sector mean. Large gaps often invite a closer look at Schrodinger's growth, margins, and balance sheet.

Profit Margin shows how effectively Schrodinger converts resources into returns. At -40.6%, SDGR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -83.39% in the prior-year period — up 51.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SDGR's profit margin (-40.6%), review year-over-year change from -83.39%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.